Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the appointment of...
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Investment Analysts’ price target changes for Tuesday, August 15th: Arcellx (NASDAQ:ACLX) had its price target increased by HC Wainwright from $49.00 to $50.00. The firm currently has a buy rating on the stock. Arcellx (NASDAQ:ACLX) had its target price increased by Robert W. Baird from $40.00 to $52.00. They currently have an outperform rating on […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday after Wedbush raised their price target on the stock from $17.00 to $19.00. Wedbush currently has an outperform rating on the stock. Alpine Immune Sciences traded as high as $14.92 and last traded at $13.99, […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw an uptick in trading volume on Monday . 51,423 shares traded hands during trading, a decline of 64% from the previous session’s volume of 141,744 shares.The stock last traded at $13.52 and had previously closed at $13.58. Alpine Immune Sciences Trading Down 2.0 % The […]